CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,508 shares (to pay taxes)
- 4 Shares withheld for taxes President & COO gave up 16,002 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Planned sale President & COO sold 96,950 shares at $10.92 ($1,058,694)
- 4 Shares withheld for taxes CFO gave up 1,896 shares (to pay taxes)
- 4 Grant or award Director acquired 1,570 shares (grant or award)
- 4 Grant or award Director acquired 1,328 shares (grant or award)
- 4 Grant or award Director acquired 1,207 shares (grant or award)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,506 shares (to pay taxes)
- 4 Grant or award Director acquired 3,366 shares (grant or award)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Shares withheld for taxes President & COO gave up 12,377 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 3,000,000 shares at $11.05 ($33,150,000)
- 4 Shares withheld for taxes 10% owner gave up 133,911 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 1,913 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 22,043 shares (to pay taxes)
- 4 Option exercise Pres&Chief Investment Officer acquired 71,365 shares (option exercise)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 6 shares (to pay taxes)
- 4 Shares withheld for taxes President & COO gave up 16,003 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
Page 14 of 26 · 511 filings